BMRN Biomarin Pharmaceutical Inc

$54.70 -0.60%

Healthcare · Pharmaceutical Preparations

Biomarin Pharmaceutical Inc (BMRN) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $10.6 billion. Shares last traded at $54.70, 17.0% below their 52-week high. Over the past year the stock is down 0.5%. BMRN trades at a price-to-earnings ratio of 30.30, above the Pharmaceutical Preparations median of 16.82. Net profit margin is 10.8%, above the peer median of -0.1%. Revenue grew 12.9% year over year.

Market Cap

$10.6B

Shares Out

193.3M

EPS (TTM)

$5.72

P/E Ratio

9.56

P/S Ratio

3.28

P/B Ratio

1.70

Dividend / Share

—

Dividend Yield

—

52-Week High

$65.91

52-Week Low

$49.29

Volume

99,550

Avg Vol (3m)

114,425.063

Performance

-1.49%

+9.80%

-0.59%

+5.69%

YTD

-8.01%

-0.52%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

49.22

SMA (50)

$54.24

SMA (200)

$55.66

Price vs SMA50

+0.84%

Price vs SMA200

-1.74%

ATR (14)

$2.24

Financials

Revenue

$3.2B

Net Income

$349M

Gross Margin

—

Operating Margin

12.7%

Net Margin

10.8%

Return on Equity

5.6%

Return on Assets

4.1%

Current Ratio

5.81

Debt / Equity

0.23

Revenue Growth (YoY)

+12.9%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.54	2026-05-05
FY 2025	$1.80	2026-02-26
Q3 2025	$2.04	2025-10-28
Q2 2025	$2.19	2025-08-05
Q1 2026	$0.95	2026-05-05
FY 2025	$2.21	2026-02-26

Full earnings history →

Pharmaceutical Preparations peers

BMRN vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

30.30 / 16.82 med

+80% premium

P/S vs peers

3.28 / 3.54 med

-7% discount

Net margin vs peers

10.8% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.